Columbus has a number of physicians with expertise in addiction medicine who are approved to write prescriptions for buprenorphine (suboxone). Suboxone is highly useful in eliminating uncomfortable opioid withdrawal symptoms. Suboxone has been available for over 10 years, and similar to methadone, it has been used effectively to help many patients find relief from a debilitating opioid addiction. Suboxone is generally taken once per day and may be purchased as a thin film which dissolves under the tongue (medically referred to as sublingual). If you are a local physician aiming to treat Columbus residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.
6810 Perimeter Drive, Suite 100 – Dublin, OH
Call: (800) 357-3811
The growing problem around opioid addiction continues to receive coverage in the media, and it has become a topic of discussion on the campaign trail because candidates are being approached throughout the country by concerned families and citizens.
Marcia Taylor, President of Partnership For Drug Free Kids, provided testimony in January to a Senate Judiciary Committee on the need to increase funding for drug prevention and drug treatment. Proposed for consideration is the CARA Senate Bill which stands for Comprehensive Addiction and Recovery Act. CARA would allocate funding for drug treatment and prevention resources with a goal of getting more addicted individuals into treatment, and better educating both parents and teens on the dangers of recreational opioid use.
CARA would also address the need to distribute naloxone across the U.S. to aid in the fight to reduce deaths from opioid overdose. Local law enforcement would be trained on the administration of naloxone. Prescription drug monitoring programs would also receive increased support under CARA.
Methadone and Suboxone have become familiar interventions for anyone knowledgeable on opioid addiction issues. Most state-funded opioid treatment programs in the United States are currently full and have waiting lists of addicted people who are eager to participate in medication-assisted treatment.
In America, there has been a notable expansion in recent years of treatment programs who utilize methadone or suboxone to help patients. While many of these programs are private self-pay, Medicaid presently pays for methadone-based treatment approaches in a number of U.S. states. The number of private pay programs currently outnumber state-funded and Medicaid-funded programs by a substantial margin.
An article in the Huffington Post recently addressed President Obama’s public comments on expanding access to opioid treatment, particularly medication-assisted treatment (MAT) like methadone or buprenorphine (suboxone).
Many members of the treatment industry and recovery community do not have a realistic grasp on the role that medication-assisted treatment can play in recovery from severe opioid addiction. Historically, the recovery community has not regarded those utilizing methadone or suboxone as truly in recovery. They emphasize total abstinence, even from methadone, despite the fact that methadone and buprenorphine have restored individuals to normal functioning and even saved lives in many cases.
There was a time some years ago, in the 12 step community, when individuals were chastised for taking psychotropic medication for depression or other mental health disorders. This criticism came from a fundamental lack of knowledge about the biological basis for many mental health disorders. Similarly, medication-assisted treatment interventions have been the subject of misunderstanding and unwarranted rejection by those with limited education on varied treatment approaches.
As America’s opioid problem continues to grow, we need real solutions rooted in medical science and research. At this point in time, medication-assisted treatment has been in use long enough to clearly demonstrate its usefulness in facilitating personal recovery from addiction.
In 2015, we saw numerous local and national political figures rally around families that have been impacted by heroin overdoses and the heartbreaking loss of loved ones. Opioid addiction has finally come into focus within the mainstream media, and even current Presidential candidates have begun to address this as an important issue which commands attention and a solution.
It was announced late last month that CVS Drugstores intends to expand their provision of non-prescription naloxone into 12 additional U.S. States. Currently, they provide naloxone over-the-counter in Rhode Island and Massachusetts, but will begin offering the life-saving medication in California, Minnesota, Mississippi, Arkansas, Montana, New Jersey, North Dakota, Pennsylvania, Tennessee, Utah, South Carolina, and Wisconsin.
Naloxone has gained attention in recent years due to its ability to reverse opioid overdoses. Over 44,000 people have died annually in the United States from drug overdose with a majority of those stemming from heroin or prescription pain medication. Naloxone has been successfully utilized in emergency rooms and on site in communities around the country reversing opioid overdose and saving thousands of lives.
It is critically important to recognize that people who have suffered with addiction are sometimes close to a lasting recovery. There is a popular expression used lately that is somewhat stark though true and thought-provoking. The expression goes “You can’t recovery if you’re dead.” While this may sound off-putting to some, it reminds us that people stuck in years of painful addiction can, and do, change. We would much rather have naloxone readily available to save a life and to provide a son, daughter, or friend the opportunity to change direction.
An addicted individual could be much closer to choosing a life of recovery than we might imagine. This happens on a daily basis. How, and when, someone recovers from addiction is hard to predict. All we can do is to offer them an open door to a new and better life.
Chuck Rosenberg, the new chief of the Drug Enforcement Administration, has expressed serious concerns about the continuing opioid addiction problem in America and the pervasive spread of heroin addiction in particular.
A Fox News article highlighted Mr. Rosenberg’s discussion of how the USA represents only 5% of the world’s population – but consumes 95% of the world’s hydrocodone. His position is that rampant overprescribing of opioids has been occurring for years. As individuals become addicted to prescription medications and are then cut off from further prescription refills, many turn to the illegal purchase of street opiates.
“Street” opiates are sold at a premium – often more than people can afford. This leads to increased crime in order to support the expensive habit or turning to heroin since it is reported to only cost about 20% of hydrocodone on the black market.
The Fox article states that nearly 44,000 per year are dying from drug overdose and that half of those overdoses are from prescription medications. Casualty rates have almost doubled over the last few years.
Also in the news last week was an announcement from Hillary Clinton that if elected President she plans to dedicate billions to opioid treatment. There are other candidates as well, including governor Chris Christie, that have expressed a similar commitment to addressing the opioid addiction epidemic. The groundswell of concern regarding opioid addiction has gained momentum over the past 2 years and is now an audible siren capturing the attention of many governmental leaders. It has become a real health hazard that cannot be ignored any longer.
To locate various methadone clinics and suboxone-approved physicians near your location, please visit our:
Search Clinics By State page.